Skip to Main Content
Legislation Search

H.R. 4958: Grocery Reform And Safety Act

This bill, titled the Grocery Reform and Safety Act, proposes changes to the regulations concerning food substances that are classified as "generally recognized as safe" (GRAS). Here are the main points of the bill in layman's terms:

Changes to GRAS Regulations

The bill amends existing laws to clarify the definition and requirements around substances considered GRAS, which are food items or additives assumed to be safe by experts in the field without needing pre-market approval from the FDA.

New Notification Requirements

  • Manufacturers intending to use a substance as GRAS must now notify the Food and Drug Administration (FDA) before they begin using it, especially if it’s a new use or a substance that was not previously marketed in food.
  • They must include detailed information in their notification, such as:
    • Identity and composition of the substance.
    • Manufacturing process.
    • Intended effects and safety evidence, including data on potential health impacts.

Safety Reassessments

Every three years, the FDA is required to reassess the safety of at least ten selected food substances or classes of substances that were previously considered GRAS. This reassessment will involve:

  • Evaluating updated information on dietary exposure and cumulative health effects.
  • Asking manufacturers to conduct and submit safety evaluations for substances under review.

Public Access and Input

The bill mandates that once a notification is accepted, the FDA must make all relevant information, including safety data and public comments, accessible on their website. There will be a public comment period lasting at least 60 days after the notification is made.

Consequences for Non-Compliance

If a manufacturer fails to comply with these new regulations, the FDA can revoke a previously granted status that recognized the substance as GRAS. Additionally, the bill establishes monetary penalties for violations of its provisions.

Funding and Resources

The bill authorizes the necessary funds to implement these new oversight and assessment procedures, ensuring that the FDA has the resources required to manage the increased workload effectively.

Definitions Clarified

The bill includes specific definitions for terms related to safety assessments, such as:

  • Carcinogenic: A substance that can cause cancer.
  • Cumulative Effects: The combined health effects of related substances.
  • Developmental Toxicity: Adverse effects on development due to exposure to the substance.

Relevant Companies

None found.

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

5 bill sponsors

Actions

2 actions

Date Action
Aug. 12, 2025 Introduced in House
Aug. 12, 2025 Referred to the House Committee on Energy and Commerce.

Corporate Lobbying

1 company lobbying

Potentially Relevant Congressional Stock Trades

Estimated excess return of the underlying stock since the transaction
Politician Stock Transaction Filed Traded
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $15,001 - $50,000
Apr 07, 2026 Mar 30, 2026 -23.99%
Congress pfp
Laura Friedman D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Exchange $1,001 - $15,000
Apr 17, 2026 Mar 24, 2026 -21.83%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $15,001 - $50,000
Apr 07, 2026 Mar 23, 2026 -22.12%
Congress pfp
Richard McCormick R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Apr 07, 2026 Mar 19, 2026 -23.59%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Apr 07, 2026 Mar 10, 2026 -23.39%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $15,001 - $50,000
Mar 10, 2026 Feb 27, 2026 -26.09%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $15,001 - $50,000
Mar 09, 2026 Feb 24, 2026 -24.69%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
Mar 09, 2026 Feb 18, 2026 -23.96%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
Mar 09, 2026 Feb 18, 2026 -23.96%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $15,001 - $50,000
Mar 09, 2026 Feb 17, 2026 -23.75%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Mar 09, 2026 Feb 10, 2026 -22.38%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABORATORIES
Purchase $15,001 - $50,000
Mar 10, 2026 Feb 05, 2026 -22.22%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $15,001 - $50,000
Feb 06, 2026 Jan 29, 2026 -17.38%
Congress pfp
Thomas H. Kean, Jr. R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Feb 19, 2026 Jan 29, 2026 -17.38%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $15,001 - $50,000
Feb 06, 2026 Jan 23, 2026 -19.15%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN-
Sale $1,001 - $15,000
Feb 06, 2026 Jan 22, 2026 -20.12%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $15,001 - $50,000
Feb 06, 2026 Jan 22, 2026 -20.12%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Jan 12, 2026 Dec 19, 2025 -32.31%
Congress pfp
Julie Johnson D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Jan 15, 2026 Dec 18, 2025 -33.06%
Congress pfp
Julia Letlow R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Jan 13, 2026 Dec 08, 2025 -30.15%
Congress pfp
Byron Donalds R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Jan 07, 2026 Dec 04, 2025 -32.00%
Congress pfp
Byron Donalds R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Jan 07, 2026 Dec 04, 2025 -32.00%
Congress pfp
Gilbert Ray Cisneros, Jr. D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Dec 15, 2025 Nov 18, 2025 -38.38%
Congress pfp
Julie Johnson D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Dec 11, 2025 Nov 13, 2025 -36.06%
Congress pfp
Richard McCormick R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Dec 09, 2025 Nov 05, 2025 -32.57%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
Nov 06, 2025 Oct 30, 2025 -32.25%
Congress pfp
Ro Khanna D / House
ABT logo
ABT DC ABBOTT LABORATORIES
Sale $1,001 - $15,000
Nov 06, 2025 Oct 30, 2025 -32.25%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
Nov 06, 2025 Oct 30, 2025 -32.25%
Congress pfp
Rick Larsen D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Oct 16, 2025 Oct 06, 2025 -38.51%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Sale $15,001 - $50,000
Sep 11, 2025 Aug 21, 2025 -43.65%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Sale $15,001 - $50,000
Sep 11, 2025 Aug 21, 2025 -43.65%
Congress pfp
Julie Johnson D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Sep 11, 2025 Aug 14, 2025 -40.58%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $1,001 - $15,000
Sep 09, 2025 Aug 06, 2025 -43.59%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $1,001 - $15,000
Sep 09, 2025 Aug 06, 2025 -43.59%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $1,001 - $15,000
Sep 09, 2025 Aug 04, 2025 -43.35%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $1,001 - $15,000
Sep 09, 2025 Aug 04, 2025 -43.35%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Purchase $1,001 - $15,000
Aug 13, 2025 Jul 31, 2025 -41.11%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Purchase $1,001 - $15,000
Aug 12, 2025 Jul 31, 2025 -41.11%
Congress pfp
Thomas H. Kean, Jr. R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 20, 2025 Jul 21, 2025 -40.69%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Aug 11, 2025 Jul 18, 2025 -40.45%
Congress pfp
Lisa C. McClain R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Aug 13, 2025 Jul 10, 2025 -46.22%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Sale $50,001 - $100,000
Jul 07, 2025 Jun 27, 2025 -48.29%
Congress pfp
Lisa C. McClain R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 13, 2025 Jun 24, 2025 -51.65%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Sale $15,001 - $50,000
Jul 07, 2025 Jun 16, 2025 -50.80%
Congress pfp
Jefferson Shreve R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $50,001 - $100,000
Jun 22, 2025 May 12, 2025 -53.77%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
May 12, 2025 Apr 23, 2025 -63.55%
Congress pfp
Bruce Westerman R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
May 12, 2025 Apr 21, 2025 -69.13%
Congress pfp
Ro Khanna D / House
ABT logo
ABT -ABBOTT LABORATORIES
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -68.12%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -68.12%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -68.12%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -68.12%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -68.12%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -68.12%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES
Sale $1,001 - $15,000
May 12, 2025 Apr 04, 2025 -68.12%
Congress pfp
Byron Donalds R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Apr 14, 2025 Mar 20, 2025 -54.67%
Congress pfp
Byron Donalds R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Apr 14, 2025 Mar 20, 2025 -54.67%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $1,001 - $15,000
Apr 10, 2025 Mar 12, 2025 -58.15%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $1,001 - $15,000
Apr 10, 2025 Mar 12, 2025 -58.15%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Apr 10, 2025 Mar 06, 2025 -57.49%
Congress pfp
Bruce Westerman R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Apr 16, 2025 Mar 03, 2025 -57.57%
Congress pfp
Shelley Moore Capito R / Senate
ABT logo
ABT Abbott Laboratories
Sale (Partial) $1,001 - $15,000
Mar 06, 2025 Feb 24, 2025 -52.33%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Mar 06, 2025 Feb 13, 2025 -48.26%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Feb 10, 2025 Jan 29, 2025 -47.68%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Feb 10, 2025 Jan 28, 2025 -46.90%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Feb 06, 2025 Jan 17, 2025 -39.55%
Congress pfp
Jared Moskowitz D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Feb 10, 2025 Jan 15, 2025 -38.81%
Congress pfp
Jared Moskowitz D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Feb 10, 2025 Jan 15, 2025 -38.81%
Congress pfp
Jared Moskowitz D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Feb 10, 2025 Jan 15, 2025 -38.81%
Congress pfp
Markwayne Mullin R / Senate
ABT logo
ABT Abbott Laboratories
Sale (Full) $1,001 - $15,000
Jan 31, 2025 Jan 08, 2025 -41.71%
Congress pfp
Emily Randall D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Feb 11, 2025 Jan 06, 2025 -39.66%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Feb 06, 2025 Jan 02, 2025 -42.19%
Congress pfp
Thomas H. Kean, Jr. R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Jan 22, 2025 Dec 16, 2024 -37.16%
Congress pfp
Markwayne Mullin R / Senate
ABT logo
ABT Abbott Laboratories Common Stock
Sale (Partial) $15,001 - $50,000
Dec 31, 2024 Dec 11, 2024 -38.08%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Sale $15,001 - $50,000
Dec 16, 2024 Nov 19, 2024 -43.53%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Sale $15,001 - $50,000
Dec 16, 2024 Nov 19, 2024 -43.53%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Sale $15,001 - $50,000
Dec 05, 2024 Nov 12, 2024 -41.74%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Purchase $50,001 - $100,000
Dec 16, 2024 Nov 04, 2024 -48.24%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Purchase $50,001 - $100,000
Dec 16, 2024 Nov 04, 2024 -48.24%
Congress pfp
Julia Letlow R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Jan 13, 2026 Oct 23, 2024 -46.05%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Purchase $50,001 - $100,000
Sep 16, 2024 Sep 09, 2024 -52.81%
Congress pfp
John James R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Sale $1,001 - $15,000
Sep 06, 2024 Sep 04, 2024 -50.38%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Sep 11, 2024 Aug 19, 2024 -46.58%
Congress pfp
Michael T. McCaul R / House
ABT logo
ABT ABBOTT LABS
Purchase $50,001 - $100,000
Sep 16, 2024 Aug 09, 2024 -50.59%
Congress pfp
Josh Gottheimer D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 15, 2024 Jul 29, 2024 -44.54%
Congress pfp
Thomas H. Kean, Jr. R / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 19, 2024 Jul 23, 2024 -41.72%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Aug 07, 2024 Jul 18, 2024 -38.61%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Aug 07, 2024 Jul 18, 2024 -38.61%
Congress pfp
Jared Moskowitz D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 19, 2024 Jul 05, 2024 -41.57%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Aug 07, 2024 Jul 02, 2024 -42.23%
Congress pfp
Kathy E. Manning D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 -42.23%
Congress pfp
Kathy E. Manning D / House
ABT logo
ABT ABBOTT LABORATORIES COMMON STOCK
Purchase $1,001 - $15,000
Aug 16, 2024 Jul 02, 2024 -42.23%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Jun 05, 2024 May 29, 2024 -45.68%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Jun 05, 2024 May 20, 2024 -46.88%
Congress pfp
Ro Khanna D / House
ABT logo
ABT ABBOTT LABORATORIES CMN
Purchase $1,001 - $15,000
Jun 05, 2024 May 20, 2024 -46.88%